Abstract
The effects of age, gender, weight, age at onset, psoriasis severity, nail involvement, and presence of psoriatic arthritis at baseline on the efficacy of ixekizumab in patients with moderate-to-severe psoriasis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have